TP53 and breast carcinoma: JmjD5 is widely overexpressed in several types of tumors (e.g., in leukemia and breast cancer [281]) and a knockout in a MCF7 breast cancer cell line resulted in reduced proliferation [42], and its function appears to be interrelated with the tumor suppressor p53.